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Abstract 
The purpose of this project is to generate double 
mutants for p53 and BubRl in a BALB/c background that is 
known to have an increased susceptibility to mammary 
tumors. Our hopes are that the two mutations in a BALB/c 
background would create a mouse model susceptible to 
mammary gland tissue tumorigenesis. P53 and BubRl mutants 
are characterized by high tumor susceptibility due to 
dysfunctions in the cell cycle checkpoints Gl/S and the 
spindle assembly checkpoint. 
Our initial analysis indicates that we have created 
double mutants in an 87.5% pure BALB/c background. We have 
not yet observed cancer in the mammary tissue; however, we 
have seen other cancer formations and abnormalities in the 
colon that may be precancerous. Our future goals are to 
backcross our BALB/c double mutants a total of ten times 
(NIO) to achieve a pure BALB/c background. We will 
continue to monitor the colony for tumor formation, 
specifically in the mammary tissue. We also hope to see 
the embryonic lethality of BubRl nullizygous mutants 
rescued in a pure BALB/c and nullizygous p53 background. 
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Introduction 
Cancer is the uncontrolled proliferation of cells 
that occurs when mistakes in DNA repair and replication 
lead to dysfunctional cell cycle checkpoints. The cell 
cycle is the necessary and ubiquitous process that allows 
all organisms to survive and grow. Because the cell cycle 
is such an important function for the proliferation of 
cells, it is regulated by three important checkpoints. 
These checkpoints occur to chronologically check for DNA 
damage, accurate DNA replication and proper spindle 
alignment before chromosomal division; this activity 
ensures that genetic integrity is maintained during the 
equal distribution of genomic content to the daughter 
cells. 
The Cell Cycle 
The genetic material of an organism is found on its 
DNA which is packed into chromosomes. Cellular division 
requires the accurate replication and correct segregation 
of identical chromosomes into two daughter cells. The goal 
of the organism (at a cellular level) is to form two 
duplicate daughter cells, and the cell cycle is the means 
by which this achieved. 
The cell cycle is comprised of four different phases, 
Gl, S, G2 and mitosis. Gl is the first stage a cell enters 
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upon completing cytokinesis, or the division of cytoplasm 
between daughter cells. The Gl phase can last from a few 
hours to a few years. When a cell stops dividing or is 
inactive, this is known as GO. The Gl phase is the point 
at which the cell actively grows and produces RNA and the 
proper proteins it needs to begin DNA synthesis. 
The next step in the cell cycle is DNA replication 
which occurs during the S phase. DNA replication results 
in the production of sister chromatids which contain exact 
copies of the cell's genetic information. Sister 
chromatids are linked at the centromere. It is here at the 
centromere that a protein structure known as the 
kinetochore forms. This structure serves as a point at 
which microtubules attach during mitosis to separate the 
sister chromatids into their respective daughter cells. 
Before this segregation can happen, however, the cell must 
go through the G2 phase in which it doubles in size and 
continues to produce proteins necessary for the 
continuation of the cell cycle. 
Mitosis is the final phase of the cell cycle and is the 
phase in which cellular division actually occurs. Mitosis 
will ideally result in two identical progeny and is made up 
of five stages: prophase, prometaphase, metaphase, 
anaphase, and telophase. Prophase, the initial stage of 
4 
mitosis, is characterized by chromosome condensation and 
the formation of mitotic spindle, a network of 
microtubules. The prometaphase stage follows in which the 
nuclear membrane disintegrates and allows the microtubules 
to attach at the kinetochores of the sister chromatids. 
The chromatids then begin to migrate to the mid line of the 
cell known as the metaphase plate. Metaphase is marked by 
the complete alignment of the chromatids along the mid-line 
of the cell. The sister chromatids are attached at the 
kinetochore which is joined with microtubules from opposite 
poles of the cell. Anaphase begins if there is proper 
alignment of the chromatids and attachment to 
microtubules. Sister chromatids separate at their 
kinetochores during anaphase and are pulled towards 
opposite poles of the cell by the microtubules. Telophase 
then marks the end of mitosis. In this stage, the nuclear 
membrane reforms and cellular division is complete upon 
cytokinesis. If the cell cycle works properly, the result 
is two indistinguishable daughter cells. 
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Figure 1. Microscopic photographs showing each of the five stages of 
mitosis. (Image from http://tidepool.st.usm.edu/crswr/mitosis.html) . 
Cell Cycle Checkpoints 
In order to ensure that DNA is replicated without 
mistakes and the sister chromatids are properly lined along 
the metaphase plate and separated equally into each 
daughter cell, the cell cycle has three checkpoints. The 
first checkpoint is known as Gl/S and occurs as the 
transition between the Gl and S phases. This checkpoint is 
activated by DNA damage and prevents replication until the 
damage is fixed, or, if the mistakes are irreparable, it 
causes the cell to go through apoptosis or cell death. The 
next checkpoint occurs at the transition between G2 and 
mitosis. This cell cycle arrest allows the cell to check 
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the DNA template and the newly replicated DNA for any 
damages or mistakes before the cell moves on to divide and 
distribute its DNA. The final checkpoint of the cell is 
the mitotic spindle checkpoint. It is here that 
microtubules from opposite poles of the cell are checked to 
be properly attached to the sister chromatids on the 
equatorial plate so that tension is generated across the 
kinetochore. 
Important Checkpoint Proteins 
p53: Because cancer is a disease characterized by the 
uncontrolled proliferation of cells, it is important to 
study the mechanisms of the cell cycle to uncover important 
genes and proteins that are responsible for proper 
checkpoint function. Mutations in these genes or loss of a 
functioning protein may lead to a loss of cell cycle 
control and, ultimately, a cancer phenotype. One of the 
most observed mutations in human cancers occurs in the p53 
gene. P53 is a checkpoint protein that is active in both 
the Gl/S and G2/M checkpoints. This prevalence of p53 
mutations makes the study of its function in the cell cycle 
of utmost importance in understanding cancer and its 
possible treatment therapies. 
P53 is a tumor suppressor that is capable of inducing 
a great number of genes in response to DNA damage and toxic 
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insult to the genome. The induced genes serve to arrest 
the cell cycle, induce the transcription of proteins that 
negatively regulate p53 levels, or promote apoptosis in the 
event of irreparable DNA insult. P53 is activated by 
upstream ATM/ATR kinases and the activated form of p53 
signals the cell to arrest or die. The consequences of p53 
activation protect the cells DNA from accumulating errors 
by continuing to divide with damaged DNA. 
As explained above, p53 serves an obviously important 
role in maintaining genomic integrity by controlling the 
induction of cell cycle checkpoints or, in the worst cases, 
apoptosis. It is no surprise then that p53 mutations or 
loss are so often seen in cancer because they prevent p53 
from activating cell cycle arrest or apoptosis (Goodsell, 
1999). Without p53, the cell continues to divide, 
unchecked, with damaged or broken DNA, and these mutations 
perpetuate the occurrence of yet more mistakes during the 
course of several cell divisions (Ljungman, 2000). 
BubRl: The BubR1 protein plays a major role in the mitotic 
spindle checkpoint. It ensures the proper attachment of 
microtubules to the kinetochores prior to anaphase and the 
correct, subsequent segregation of sister chromatids. 
BubR1 is, therefore, exceedingly important in the 
prevention of chromosomal instability (eIN). As could be 
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expected, mutated forms of BubRl have been seen in cancer 
phenotypes, specifically colon cancer; however BubRl 
deletion appears to be rare (Cahill, 1998). 
The exact function of BubRl is quite complex, and 
though many of its roles have been uncovered, there is 
still a great deal of information to gather on the full 
function of this protein in the cell cycle. It has been 
proven that BubRl protein levels peak during the G2/M phase 
of the cell cycle, which is evidence for its function in 
the spindle assembly checkpoint (Davenport, 1999). BubRl 
has been shown to interact with the centromeric motor 
protein E (CENP-E), and it localizes to the kinetochores of 
unaligned chromosomes followed by the localization of CENP-
E (Chan, 1998). BubRl prevents mitotic exit until all the 
chromosomes are properly aligned, and one of its main roles 
is to sense tension across the kinetochore, which signals 
microtubule attachment (Skoufias, 2001). When BubRl is 
activated through phosphorylation facilitated by Mad1, it 
interacts with Cdc20, the cofactor that binds the Anaphase 
Promoting Complex (APC) and allows the cell to continue 
through anaphase. BubRls interaction with Cdc20 
effectively arrests the cell during mitosis so that 
adequate spindle attachment and chromosome separation may 
occur (H. Yu, 2002). 
9 
Since BubRl is so important to the spindle checkpoint 
and in avoiding CIN, its failure or a loss of the gene 
itself could result in a severe threat to genomic 
instability and possible aneuploidy or polyploidy, 
characteristics often seen in cancer cells. In order to 
determine the necessity of BubRl, knock-out mice have been 
created using a gene trap. The BubRl haploinsufficient 
mice were then bred to examine the effects of the loss of 
one or both BubRl alleles. It was determined that BubRl is 
an essential gene because nullizygous embryos began dying 
at 6.5 days post coitum (dpc) and were reabsorbed by 8.5 
dpc (Wang, 2004). Death was due to apoptosis, and BubRl 
was determined to be an essential protein for embryonic 
development and the monitoring of spindle assembly during 
mitosis. 
Rationale for Generating BubRl/p53 Double MUtants in a 
BALB/c background: Here, we have studied the synergistic 
effects of p53 deletions and BubRl deficiency in mice. 
Several cancer studies have shown that several mutations or 
deletions of genes involved in cell proliferation are 
required to obtain a cancer phenotype. It has already been 
observed that p53 is often seen deleted in colon cancer 
phenotypes (Cahill, 1998). We hypothesize that making p53 
heterozygous or nullizygous mice also deficient for BubR1 
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will increase the tumor susceptibility of the mice and, 
likewise, decrease the lifespan; it is also possible that 
we will observe colon cancer phenotypes. The compound 
mutants were generated and frequent health checks were 
performed to watch for the development of cancer in the 
mutant mice. 
Our double mutants for p53 and BubR1 have shown to 
have the expected increased susceptibility to 
tumorigenesis. The next step in the project was to 
generate these deficient mice into another cancer 
susceptible background known as BALB/c. BALB/c mice have 
strain-specific polymorphisms in their DNA-dependent 
protein kinase (prkdc) which makes them less able to repair 
DNA damage such as double strand breaks (DSB) (Y. Yu, 
2001) . It has been determined that post-irradiation damage 
has a much higher rate of repair in the C57BL/6 strain (our 
laboratory's common mouse strain) than in BALB/c mice (Y. 
YU, 2001). The amount of prkdc in BALB/c mice is 
significantly reduced, which is important because prkdc is 
actively involved in end-rejoining of DSB, apoptosis and 
signal transduction in the cell (Y. Yu, 2001 and Smith, 
1999). Genomic instability has thus far been seen 
specifically in mammary epithelia of female mice (Y. Yu, 
2001). Our goal was to place the already cancer 
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susceptible p53/BubRl double mutant into the BALB/c 
background in hopes of seeing a mammary gland cancer 
phenotype in our female mice. 
Materials and Methods 
Generation of BubRl/p53 mice in BALB/c background: In 
order to generate BubRl deficient mice, a gene trap 
approach was used to disrupt the BubRl gene. We obtained 
embryonic stem (ES) cells with a gene trap inserted into 
BubRl from Bay Genomics. The trap was shown to have 
inserted into intron 2 of BubRl. This was confirmed by PCR 
and Southern blotting. When the insertion was confirmed, 
the trapped cells were injected into 3.5 dpc blastocysts 
and inserted into a pseudo-pregnant C57BL/6 female mouse. 
Nine pups were generated, four of which produced germ line 
litters for the BubRl deletion. Tails tips were cut and 
taken for genetic analysis, which indicated equal numbers 
of wild type and heterozygous offspring. To generate 
p53/BubRl double mutants, the BubRl mice were mated to our 
p53 knockout strains. 
Once the double mutant colony was established, we 
obtained BALB/c mice from Jackson Laboratories. Mice 
heterozygous or nullizygous for p53 and heterozygous for 
BubRl were mated with the BALB/c females to begin producing 
double mutant offspring in a BALB/c background. 
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DNA Extraction: To isolate DNA for our genotyping 
experiments, we clip the tails of our mice when we wean 
them. We then incubate the tail overnight at 55°C in 500~L 
tail lysis buffer (50mM Tris pH 7.5, 50mM EDTA, 100mM NaCl, 
and 1% SDS), 10~L 10ng/~L Proteinase K and 1.25~L 2M DTT. 
After incubation, 500~L phenol chloroform is added to the 
tails and mixed by hand. The samples are then 
microcentrifuged for two minutes at 13,OOOrpm. 
Approximately 400pL of the top, aqueous layer in isolated 
and placed in a second tube. The bottom layer is 
discarded. To this second tube, 800~L 100% ethanol is 
added and the samples are mixed gently with the hand until 
a precipitate if formed. This precipitate is the DNA and 
is removed from the ethanol and placed into a final tube 
with 100~L 5mM Tris. The DNA is allowed to equilibrate 
overnight at room temperature before being used for 
genotyping. 
BubRl Genotyping: Polymerase chain reaction (PCR) was used 
to genotype BubR1 mice. For each reaction, 200ng of DNA is 
added to a 23pL PCR master mix composed of 1X PCR buffer, 
1.5mM MgC1 2 , 1.5pL of dNTP, 0.2pM of forward and reverse 
primers and 1.0 unit of Platinum Taq DNA Polymerase. For 
the insertion and wild type PCR, the conditions are as 
follows: a two minute denaturation step at 94°C precedes 
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another denaturation step for 30 seconds at 94°C, annealing 
for 30 seconds at 54°C, and finally extension for two 
minutes and fifteen seconds at 72°C. This is repeated for 
32 complete cycles and is finalized by a five minute 
extension step at 72°C. The trap PCR conditions are 
similar except for a decrease in extension time (one minute 
and fifteen seconds) . The primers for the trap PCR are 
1300f and 2000rr which create a product about 665 base 
pairs (bp) in length. The primers used to verify the 
correct insertion of the trap are Bub2e2s and 984r, which 
gives a PCR product of 2.4kbp. The two products are proof 
of the presence and correct insertion (location) of the 
gene trap in BubRl. To determine the presence of the wild 
type allele, primers Bub2e2s and Bub2in2a are used and give 
a PCR product 2.25kbp in length. This product indicates 
the presence of an uninterrupted BubRl gene, specifically 




TRI ... TR2 TR3 ...... 
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Figure 2. Schematic showing the trap insert into the bubRl gene. TR2 
and TR3 represent the primers used to determine the presence of the 
trap. GSl and TRl represent the primers to determine if the trap was 
inserted into the correct place in the genome. GSl and GS2 represent 
the primers used to characterize the wild type allele. 
P53 Genotyping: The p53 genotype of mice is determined by 
Southern blot assays. Two and one half micrograms of DNA 
is digested with BamBi overnight at 37°C. The samples are 
then loaded into a 0.8% agarose gel containing ethidium 
bromide. Once the gel is run, the DNA is denatured with 
0.25N BCl and transferred onto a nylon membrane overnight 
in 0.4N NaOB. Once the gel is transferred, the membrane is 
rinsed in 2X SSC and incubated at 37°C for one hour to 
dry. The membrane is then place into a hybridization 
cylinder with 30mL of pre-hybridization buffer (1.3% SDS, 
2X SSPE, 1% milk, and 2mg denatured salmon sperm DNA) for 
five to six hours at 68°C. The pre-hybridization buffer is 
then removed and hybridization buffer (10% dextran sulfate, 
1.5X SSPE, 1% SDS, and 0.5% milk) is added along with a 
radio-labeled DNA probe (l,OOO,OOOcpm/mL hybridization 
buffer) . The membrane is incubated in the radio-labeled 
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probe overnight; the buffer is then removed and the 
membrane rinsed in 2X SSC. A series of solutions are then 
used for washing the membrane for ten minutes per solution 
(Solution 1: 2X SSC, 0.1% SOS; Solution 2: 0.5X SSC, 0.1% 
SOS; Solution 3: 0.2X SSC, 0.2% SOS). Once the 
radioactivity of the membrane is between 2,000 and 3,000 
cpm, the membrane is exposed on x-ray film overnight at -
80°C. The radio-labeled probe is created using 100ng of 
ONA specific to Exons four through six of the p53 gene. 
Ba1b/C Genotypinq: To characterize a mouse as having a 
BALB/c background or being pure BALB/c, a version of PCR 
specified by Yu et al was used. The primers were labeled 
Balbf and Balbr for forward and reverse primers, 
respectively. The primers are specific for the prkdc gene 
and are targeted to analyze the presence of the prkdc 
polymorphism seen in BALB/c mice. The polymorphism 
shortens the amplified band targeted by the above primers 
from approximately 500bp to 250bp-this is analyzed in the 
final photograph of the agarose gel. The PCR reaction mix 
is the same as for BubR1 (with the exception of the 
primers). The PCR conditions are as follows: 94°C for 30 
seconds, followed by 49°C for 30 seconds, then 72°C for 30 
seconds and this is cycled 40 times. There is then a final 
extension at 70°C for ten minutes. The PCR product is then 
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digested by the enzyme BsmBl in a fashion similar to that 
used in Southern blotting. This digest is incubated at 
55°C for 3 hours. The product is then analyzed by gel 
electrophoresis on a 2% agarose gel. 
Results 
P53 Genotyping: Our p53 BMR probe is made specifically for 
mice bred in a p53 BMR background. The radio-labeled 
probe, when added to the membrane as mentioned above, binds 
to the p53 sequence wild type and mutant allele. The probe 
also binds a pseudogene regardless of its binding to the 
wild type and/or mutant allele. The binding to the 
pseudogene proves that the probe properly functioned and 
the DNA concentration was adequate for binding. Once the 
membrane is radio-labeled, washed, and the film is exposed, 
the resulting bands can be analyzed to determine the 
genotype of the specimen. 
17 
Southern Blotting 
1 2 3 4 5 
pseudogene --+ 
III mutant band 
wildtype band • 
Figure 3. Above is a picture of a Southern indicating the genotype of the p53 gene based on the 
location of various bands. Lanes 1 and 2 illustrate a wildtype p53 genotype, lanes 3 and 5 illustrate a 
nullizygous p53 genotype, and lane 4 illustrates a heterozygous p53 genotype. 
BubR1 characterization: The PCR reactions for BubR1 
genotyping (as described in Materials and Methods) are run 
on a 1% agarose gel. The gel is then photographed and can 
be analyzed in a similar fashion to the p53 membrane to 
determine genotype. Bands that appear during reactions for 
the trap and insertion PCRs indicate the presence of an 
interrupted BubR1 gene and are characteristic of 
heterozygous mice. Bands seen in the wild type PCR 
reaction are indicative of a wild type, or normal, BubR1 
allele and are characteristic of wild type mice. If no 
band is seen in the three PCRs, the mouse can be assumed to 
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have lost its wild copy of BubRl. 
Marker 
Blank well 
2 3 4 5 ~ 2 3 4 5 2 3 4 5 
Trap peR (630 bp) Insertion peR (2.4 kb) Wild-Type peR 
Figure 4. Above is a picture of all three PCRs used to genotype our BubR1 mice. The first set of bands 
is from a trap PCR, the second set from and insertion PCR and the third from a wild type PCR. Lanes 1, 
2 and 4 show bands for the trap and insertion PCRs and are results from heterozygous mice. All five 
lanes in the wild type PCR show bands which indicates that samples 1, 2 and 4 have one trapped allele 
and one normal allele and samples 3 and 5 have two trapped alleles and are wild type mice. 
Backcrossing into BALB/c: Initially, we began genotyping 
our mice in the BALB/c background using the PCR reaction 
described in Materials and Methods. However, we have run 
into difficulties with the PCR, as it produces several 
nonspecific bands, and we have reason to believe the 
results generated by Yu et al were incorrect or 
mislabeled. As a result, we began to backcross our BALB/c 
colony with a goal of eventually reaching an almost pure 
BALB/c background (considered to be NIO) . 
So far, we have performed a total of three backcrosses 
(N3) to place our p53/BubRl mice into a BALB/c background. 
With three backcrosses, we achieve an 87.5% BALB/c 
background. Our goal is to backcross our colony seven more 
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times to approach what is scientifically considered a pure 
BALB/c background. So far, we have not yet seen 
tumorigenesis occurring in the mammary tissue of our 
females, but we will continue monitoring their tumor 
susceptibility. 
Intercrosses: 
Table 1. Results from intercrosses of BubRl/pS3 double mutants in the 
BALB/c background. 
BubRl+/- p53+/- X BubRl+/- p53+/- [n=l] 
BubRl+/- p53+/- X BubRl+/+ p53 +/- [n=3] 
BubRl+/- p53-/- X BubRl+/+ p53+/- [n=l] 
~--'------------r.--'-"--'----'-'-------""-"-------'-'--'--r='---'---"--~'-----'-'--'-----r=-"----'----'--
BubRl IBubRl iBubRl WT/ !BubRl het/ iBubRl IBubRl het/ 
WT/pS3 WT iWT/pS3 het iPS3 null IpS3 WT !het/pS3 het IpS3 null 
- ! .------~.--.-----.-----,---------__r.:_--.------! 
o io !3 10 ;2 10 
These tables show the genotypes of the crossed mice as well 
as the number [n] of each type of intercross. The tables 
contain data for each possible genotype for the offspring 
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of these crosses. Mice were genotyped using the PCR and 
Southern strategies described in Materials and Methods. 
Tumor Formation: So far, we have sacrificed several mice 
with some form of an abnormality in one or many of their 
organs. As mentioned before, we have yet to observe a 
cancer phenotype in mammary tissue, but we have seen 
abnormalities in the colon of a few mice that could be 
indicative of cancer formation. This is not surprising as 
BubRl levels are often mutated in human colon cancers. The 
tumor types have yet to be determined by a pathologist, but 
the summary of the tumor or cancerous locations can be seen 
below. 
Tumor Location of Cases 
Colon 
other 
Table 2. This table shows the numbers of abnormal or cancerous tissues 
seen in sacrificed mice and indicates their specific locations. 
Future Work 
In the future we plan to backcross our BALB/c colony 
seven more times (N10 generation) to obtain the mutants in a 
pure BALB/c background. We will also determine if the pure 
BALB/c background and p53 deficiency will allow us to rescue 
the BubRl embryonic lethality observed between 6.5 and 
8.5dpc. Until then, we plan to continue monitoring our 
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colony for any novel phenotypes. As mentioned before, we 
have preliminary data that suggest increased tumor 
susceptibility in the colons of these double mutant BALB/c 
mice. Many mice have been sacrificed and determined to have 
several colon polyps which will be confirmed by a 
pathologist. 
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